Skip to main content

Table 2 Comparison of the characteristics of non-alcoholic fatty liver disease patients who continued and discontinued their follow-up exams after a liver biopsy.

From: Markedly lower follow-up rate after liver biopsy in patients with non-alcoholic fatty liver diseases than those with viral hepatitis in Japan

  Patients who maintained
their follow-up exams
(n = 68)
Patients who discontinued
their follow-up exams
(n = 67)
p-value
Age
(years: mean ± S.D.)
52.6 ± 13.4 44.9 ± 15.2 0.0035
Sex
(male/female) (%)
42 (61.8)/26 (38.2) 42 (62.7)/25 (37.3) 0.9120
AST
(IU/L: mean ± S.D.)
59.6 ± 35.0 56.4 ± 49.4 0.1208
ALT
(IU/L: mean ± S.D.)
93.6 ± 70.5 95.9 ± 65.4 0.5928
Medication
(yes/no) (%)
21 (30.9)/47 (69.4) 18 (26.9)/49 (73.1) 0.7442
Pathologic diagnosis
(NASH/simple steatosis) (%)
47 (69.1)/21 (30.9) 43 (64.2)/24 (35.8) 0.6691
  1. AST, aspartate aminotransferase; ALT, alanine aminotransferase; NASH: non-alcohol steatohepatitis.